FI921058A0 - Anvaendning av thioredoxin vid behandling av elakartade transformade celler i djur och maenniska. - Google Patents

Anvaendning av thioredoxin vid behandling av elakartade transformade celler i djur och maenniska.

Info

Publication number
FI921058A0
FI921058A0 FI921058A FI921058A FI921058A0 FI 921058 A0 FI921058 A0 FI 921058A0 FI 921058 A FI921058 A FI 921058A FI 921058 A FI921058 A FI 921058A FI 921058 A0 FI921058 A0 FI 921058A0
Authority
FI
Finland
Prior art keywords
transformade
maenniska
elakartade
djur
celler
Prior art date
Application number
FI921058A
Other languages
English (en)
Finnish (fi)
Inventor
Anders Rosen
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI921058A0 publication Critical patent/FI921058A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y108/00—Oxidoreductases acting on sulfur groups as donors (1.8)
    • C12Y108/01—Oxidoreductases acting on sulfur groups as donors (1.8) with NAD+ or NADP+ as acceptor (1.8.1)
    • C12Y108/01008—Protein-disulfide reductase (1.8.1.8), i.e. thioredoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI921058A 1989-09-12 1992-03-11 Anvaendning av thioredoxin vid behandling av elakartade transformade celler i djur och maenniska. FI921058A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8903003A SE8903003D0 (sv) 1989-09-12 1989-09-12 Novel medical use
PCT/SE1990/000578 WO1991004320A1 (en) 1989-09-12 1990-09-10 The use of thioredoxin in the treatment of malignantly transformed cells in animals and man

Publications (1)

Publication Number Publication Date
FI921058A0 true FI921058A0 (fi) 1992-03-11

Family

ID=20376862

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921058A FI921058A0 (fi) 1989-09-12 1992-03-11 Anvaendning av thioredoxin vid behandling av elakartade transformade celler i djur och maenniska.

Country Status (12)

Country Link
EP (1) EP0489113A1 (ja)
JP (1) JPH05500216A (ja)
AU (1) AU641942B2 (ja)
CA (1) CA2065454A1 (ja)
DD (1) DD298056A5 (ja)
FI (1) FI921058A0 (ja)
GR (1) GR1001151B (ja)
HU (1) HUT62932A (ja)
IE (1) IE903233A1 (ja)
PT (1) PT95284A (ja)
SE (1) SE8903003D0 (ja)
WO (1) WO1991004320A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ258392A (en) 1992-11-13 1997-09-22 Idec Pharma Corp Chimeric and radiolabelled antibodies to the b lymphocyte cellsurface antigen bp35 (cd-20) and their use in the treatment of b cell lymphona
US7744877B2 (en) 1992-11-13 2010-06-29 Biogen Idec Inc. Expression and use of anti-CD20 Antibodies
WO1998000160A1 (en) * 1996-06-28 1998-01-08 Nat Jewish Ct Immun & Respirat USE OF THIOREDOXIN-LIKE MOLECULES FOR INDUCTION OF MnSOD TO TREAT OXIDATIVE DAMAGE
EP0946192A1 (en) * 1996-12-06 1999-10-06 Garth Powis Uses of thioredoxin
US6689775B2 (en) 1999-06-03 2004-02-10 Arizona Board Of Regents, Acting On Behalf Of The University Of Arizona Uses of thioredoxin
US5919657A (en) * 1997-04-09 1999-07-06 Incyte Pharmaceuticals, Inc. Nucleic acids encoding human thioredoxin protein; related reagents
US7585645B2 (en) 1997-05-27 2009-09-08 Sembiosys Genetics Inc. Thioredoxin and thioredoxin reductase containing oil body based products
KR20010040448A (ko) 1998-01-30 2001-05-15 진센스 테크놀로지즈 인코포레이티드 티오레독신 또는 티오레독신 환원효소의 유전자와상보적인 올리고뉴클레오 타이드 서열 및 이들을 사용하는세포성장 조절 방법
CN1320044A (zh) 1998-08-11 2001-10-31 Idec药物公司 包括施用抗－cd20抗体的b－细胞淋巴瘤联合疗法
ES2543819T3 (es) 1998-11-09 2015-08-24 Biogen Inc. Tratamiento de neoplasias hematológicas asociadas con células tumorales circulantes utilizando anticuerpo quimérico dirigido contra CD20
US8557244B1 (en) 1999-08-11 2013-10-15 Biogen Idec Inc. Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody
EP1332212A2 (en) * 2000-08-25 2003-08-06 Curagen Corporation Proteins and nucleic acids encoding same
WO2004024868A2 (en) 2002-09-10 2004-03-25 National Jewish Medical And Research Center Product and process for liquefaction of mucus or sputum
MX2015013040A (es) 2013-03-15 2016-05-24 Orpro Therapeutics Inc Producto y proceso para normalización de la viscosidad del moco.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2633295B2 (ja) * 1987-06-12 1997-07-23 味の素株式会社 ヒトａｄｆをコードする遺伝子

Also Published As

Publication number Publication date
PT95284A (pt) 1991-08-14
HUT62932A (en) 1993-06-28
GR900100679A (en) 1992-01-20
WO1991004320A1 (en) 1991-04-04
GR1001151B (el) 1993-05-24
EP0489113A1 (en) 1992-06-10
CA2065454A1 (en) 1991-03-13
IE903233A1 (en) 1991-03-27
SE8903003D0 (sv) 1989-09-12
AU641942B2 (en) 1993-10-07
HU9200821D0 (en) 1992-05-28
DD298056A5 (de) 1992-02-06
AU6433690A (en) 1991-04-18
JPH05500216A (ja) 1993-01-21

Similar Documents

Publication Publication Date Title
FI881956A0 (fi) Foerfarande och anordning vid antenn- och mottagningssystem av en radioteodolit.
FI880772A0 (fi) Foerfarande foer reglering av luftkonditionering och luftkonditioneringsanordning foer anvaendning vid foerfarandet.
FI884187A0 (fi) Foerfarande och anordning foer lokalisering av elektroder faestade vid kroppen av en maenniska, i synnerhet huvudet.
FI891344A0 (fi) Foerfarande och anordning i torkningspartiet av en belaeggningsmaskin eller motsvarande.
FI921058A0 (fi) Anvaendning av thioredoxin vid behandling av elakartade transformade celler i djur och maenniska.
FI911904A0 (fi) Foerbaettringar i och vid supraledande kompositledare.
FI902100A0 (fi) Foerpackning foer upphettande eller kokande av en matprodukt i en hetluftsugn.
FI885637A0 (fi) Foerfarande vid behandling av returflaskor och behandlingsanordning foer returflaskor.
FI882128A0 (fi) Filtreringsfoerfarande och anordning foer anvaendning vid foerfarandet.
FI902024A0 (fi) Foerfarande foer maongfaldig oxidering av steroider och i foerfarandet anvaendbara gentekniskt modifierade celler.
FI883880A (fi) Foerfarande och anordning vid pollinering.
FI910340A0 (fi) Anordning foer anvaendning av svetselektroder eller svetstaenger i en motstaendsvetsmaskin.
FI884323A0 (fi) Behandlingsbaenk foer anvaendning vid fysikalisk rehabilitering och vaord.
FI883025A0 (fi) Foerfarande och anordning foer oeverbelastnings- och kortslutningsskydd vid slutstyranordningar.
FI885230A0 (fi) Anordning foer hantering av returburkar och foerfarande vid behandling av returburkar.
FI883127A0 (fi) Luftfoerdelningsfoerfarande och anlaeggning foer anvaendning vid foerfarandet.
FI904160A0 (fi) Vattenloeslig eller i vatten dispergerbar fotopolymeriserbar blandning och anvaendning av denna foer tryckningsaendamaol.
FI882312A0 (fi) Foerfarande och anordning vid pressbehandling av fiberbana.
FI885634A (fi) Anordning och foerfarande foer foerstoering av celler i tumoerer.
FI895454A0 (fi) Foerfarande och kopplingssystem foer kontroll av cellers skick i seriekopplade ackumulatorer vid anvaendning av servicefria slutna ackumulatorer.
FI883126A0 (fi) Foerfarande vid torkning av vattenhaltigt aemne i en kraftverksprocess och torkanordning foer anvaendning vid foerfarandet.
FI883125A0 (fi) Torkningsfoerfarande i kraftverksprocess och torkanordning foer anvaendning vid foerfarandet.
FI885575A0 (fi) Foerfarande och anordning foer anvaendning vid inlindningsmaskiner.
FI882763A (fi) Punktventilationsfoerfarande foer arbetspunkt och anlaeggning foer anvaendning vid foerfarandet.
FI881849A0 (fi) Foerpapprings- och taningsfoerfarande och vid foerfarandet anvaend tana-ark.

Legal Events

Date Code Title Description
FD Application lapsed